Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bio-Rad Laboratories (NY: BIO ) 301.92 +5.10 (+1.72%) Official Closing Price Updated: 7:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 235,083 Open 297.82 Bid (Size) 141.37 (1) Ask (Size) 553.00 (1) Prev. Close 296.82 Today's Range 291.66 - 303.06 52wk Range 261.59 - 431.79 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024 July 17, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire S&P 500 Ends First Half Shy Of All-Time Highs. Here Are The Leaders And Laggards — And 5 Stocks That Could Outperform In Next 6 Months June 30, 2024 The market's resilient run has made traders cautious of a potential correction, but analysts remain optimistic about its trajectory. Via Benzinga Topics Stocks Exposures US Equities Performance YTD -7.95% -7.95% 1 Month +6.35% +6.35% 3 Month +7.78% +7.78% 6 Month -3.49% -3.49% 1 Year -27.58% -27.58% More News Read More OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics June 05, 2024 Via AB Newswire The Analyst Landscape: 4 Takes On Bio-Rad Laboratories May 08, 2024 Via Benzinga Bio-Rad Laboratories: Q4 Earnings Insights February 15, 2024 Via Benzinga Earnings Scheduled For February 15, 2024 February 15, 2024 Via Benzinga Preview: Bio-Rad Laboratories's Earnings February 14, 2024 Via Benzinga OncoCyte's Innovative Approach: Potential in Precision Diagnostics June 05, 2024 Via TheNewswire.com Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group May 30, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference May 23, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024 May 07, 2024 Via InvestorPlace Bio-Rad Reports First-Quarter 2024 Financial Results May 07, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference May 01, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Announces Life Science Group Management Changes April 26, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire 96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity? April 18, 2024 Via Benzinga Topics Stocks Exposures US Equities Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 April 18, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad’s Chief Operating Officer Andrew Last to Retire April 10, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer March 20, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day February 22, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Tech Stocks Ease On Hot PPI, Yields Rise, Microsoft, Amazon Snap 5-Week Positive Streak: What's Driving Markets Friday? February 16, 2024 Via Benzinga Topics Economy Exposures Interest Rates Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday February 16, 2024 Via Benzinga Topics Stocks Exposures US Equities Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results February 15, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024 January 24, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire 10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps? January 23, 2024 Via Benzinga Topics Artificial Intelligence Economy Stocks Exposures Artificial Intelligence Interest Rates US Equities Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference January 02, 2024 From Bio-Rad Laboratories, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.